Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on July 5, 2019, covering events occurring on June 28, 2019. The company is an emerging growth company incorporated in Delaware and trades on the NASDAQ Capital Market.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, or margin data. The primary financial disclosure relates to debt obligations:
- Promissory Notes Issued: Approximately $5.05 million aggregate principal amount issued beginning March 18, 2019.
- Original Maturity Date: July 18, 2019.
- Amended Maturity Date: July 31, 2019.
Material Changes
On June 28, 2019, the Company entered into amendment agreements with holders of its promissory notes. The sole material change was the extension of the maturity date by 13 days, from July 18, 2019, to July 31, 2019. All other terms of the notes remain unchanged.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks. The document strictly reports the execution of the amendment agreement regarding the existing debt. The filing references the full text of the amendment agreement as an exhibit for complete terms.
Investor Verification Checklist
- Verify the total outstanding principal of the promissory notes as of the filing date.
- Confirm the interest rate and repayment terms of the notes, which remain unchanged per this filing.
- Review the full text of the Amendment Agreement (Exhibit 10.1) for any covenants or conditions not summarized in the report.
- Monitor the company's ability to repay the $5.05 million obligation by the new July 31, 2019 deadline.